Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
6,216,229
-
Share change
-
+5,450,042
-
Total reported value
-
$13,562,379
-
Price per share
-
$2.18
-
Number of holders
-
32
-
Value change
-
+$11,870,396
-
Number of buys
-
16
-
Number of sells
-
9
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2023
As of 30 Sep 2023,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,216,229 shares.
The largest 10 holders included
Anson Funds Management LP, MILLENNIUM MANAGEMENT LLC, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, MORGAN STANLEY, CIBC WORLD MARKET INC., Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, Long Focus Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, and BANK OF MONTREAL /CAN/.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.